TCT

transradial approach, same-day cardiac procedures, radial access, $300 million annual savings, JACC Cardiovascular Interventions study
News | Radial Access | February 22, 2017

February 22, 2017 — If hospitals can perform more...

heart team, hybird OR, structural heart team

The heart team approach was first used on a large scale in the CoreValve and Sapien TAVR trials and helped lead to excellent outcomes in high-risk patients.

Feature | Hybrid OR | February 15, 2017 | Dave Fornell

In the current era of healthcare reform and the push toward evidence-based medicine to both lower costs and improve...

Blog | Stents | February 13, 2017

Stents were the key focus of interventional cardiology for more than 20 years, but the focus has changed in recent...

 Intra-atrial shunt device (IASD) to lower left atrial pressure by creating a small left atrial to right atrial shunt.  Abraham said these devices are in early stage development with small studies to show proof of concept and demonstrate safety.

The Corvia Intra-atrial shunt device (IASD) lowers left atrial pressure by creating a small left atrial to right atrial shunt. Preliminary clinical studies have shown promise for these types of devices to improve HFpEF patient outcomes.

Feature | Heart Failure | February 10, 2017 | Dave Fornell

In the past few years there have been a number of device therapies developed to treat heart failure (HF). This is...

Blog | January 30, 2017

DAIC has worked hard to bring useful technology news and resources to our readers. While we conduct reader surveys...

Synergy stent, abluminal polymer DES, bioresorbable polymer DES, bioresorbable polymer metallic stent

The Synergy stent is the first FDA cleared drug-eluting stent to use a bioresorbable polymer drug carrier. When the polymer dissolves after about four months, the devices become a bare metal stent. The technology is supposed to reduce the rate of late stent thrombosis due to vessel inflammation caused by durable polymers.

Feature | Stents Bioresorbable | January 17, 2017 | Dave Fornell

One of the big advancements in drug-eluting stent (DES) technology has been the development of bioresorbable...

Tendyne Mitral valve

The Tendyne mitral valve being implanted. 

News | Heart Valve Technology | January 16, 2017

January 16, 2017 – In 2015, researchers and physicians at the Minneapolis Heart Institute Foundation (MHIF) were the...

OCT, intravascular imaging, stent, good stent apposition on vessel wall, TRANSFORM-OCT study

An OCT image showing good stent strut apposition against the vessel wall.

News | Stents | January 13, 2017

January 13, 2017 — Results from TRANSFORM-OCT, a prospective, randomized trial using optical coherence tomography (...

Sponsored Content | Videos | Cardiovascular Ultrasound | January 13, 2017

Detailed imaging is needed to support complex interventions for the assessment and procedure guidance.  See how the...

EXCEL Trial, TCT 2016, drug-eluting stents, CABG, surgery left main heart disease, LMCAD

Gregg W. Stone, M.D., presenting the EXCEL data at TCT 2016 during a standing room only late-breaking trial session.

Feature | Stents | January 12, 2017 | Dave Fornell

The biggest news from the 2016 Transcatheter Cardiovascular Therapeutics (TCT) meeting this past fall was the...

Medinol, BIONICS study, 12-month results, TCT 2016, drug-eluting stent, EluNIR
News | Stents Drug Eluting | January 10, 2017

January 10, 2017 — Medinol announced in December positive twelve-month clinical results from the BIONICS study. The...

Videos | Heart Valve Technology | January 03, 2017

The Valtech Cardioband transcatheter mitral annuloplasty system allows transcatheter repair of functional mitral...

NaviGate, GATE tricuspid Atrioventricular Valved Stent AVS, transcatheter tricuspid valve replacement
News | Heart Valve Technology | December 31, 2016

December 31, 2016 — NaviGate Cardiac Structures Inc. (NCSI) announced that a novel valved stent that can capture the...

valtech cardioband transcatheter annuloplasty repair for FMR, functional mitral regurgitation

The Cardioband system is among several new transcatheter mitral repair systems entering clinical trials. In many cases, repair of the native valve is preferred over replacing the valve in open-chest surgical cases. This technology will allow a less invasive alternative. 

Feature | Heart Valve Technology | December 29, 2016 | Azeem Latib, M.D.

The Cardioband System (Valtech) has recently been introduced as a potential option for transcatheter repair of the...

Overlay Init